Canada markets open in 8 hours 4 minutes

Viking Therapeutics, Inc. (1VT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
48.66+1.03 (+2.16%)
At close: 08:12AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
76,901
63,806
54,234
44,981
31,931
-
Selling General and Administrative
37,462
37,021
16,121
10,701
10,731
-
Total Operating Expenses
114,363
100,827
70,355
55,682
42,662
-
Operating Income or Loss
-114,363
-100,827
-70,355
-55,682
-42,662
-
Interest Expense
-
-
-
-
-
0
Total Other Income/Expenses Net
-
-
-42
7
40
4
Income Before Tax
-93,720
-85,895
-68,867
-54,990
-39,495
-
Income from Continuing Operations
-93,720
-85,895
-68,867
-54,990
-39,495
-
Net Income
-93,720
-85,895
-68,867
-54,990
-39,495
-
Net Income available to common shareholders
-93,720
-85,895
-68,867
-54,990
-39,495
-
Basic EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Diluted EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Basic Average Shares
88,507
94,347
76,834
77,198
72,597
-
Diluted Average Shares
88,507
94,347
76,834
77,198
72,597
-